Compare BYSI & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYSI | OM |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.0M | 85.0M |
| IPO Year | 2017 | 2020 |
| Metric | BYSI | OM |
|---|---|---|
| Price | $1.63 | $3.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 732.9K | 516.4K |
| Earning Date | 02-11-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,069,000.00 |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $0.98 | $3.10 |
| 52 Week High | $3.44 | $25.35 |
| Indicator | BYSI | OM |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 33.75 |
| Support Level | $1.82 | $3.10 |
| Resistance Level | $2.40 | $3.83 |
| Average True Range (ATR) | 0.20 | 0.28 |
| MACD | -0.04 | 0.23 |
| Stochastic Oscillator | 5.95 | 51.92 |
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.